News & Conferences

VaxForm Awarded NSF SBIR Grant

Jan 19, 2020 6:20 pm

Jan. 29, 2019 - The National Science Foundation has awarded VaxForm a SBIR Phase I grant for: Incorporation of a new adjuvant system to produce a thermally stable, orally administered Diphteria-Tetanus-Pertussis vaccine.